U.S. federal trademark · Serial No. 99112929
Biochemical and biological substances in the nature of polymers and polymer-conjugates for medical diagnostics and analysis, namely, detection of anti-PEG antibodies, anti-POEGMA antibodies, other immunogenic responses that hinder a therapeutic intervention, and companion diagnostics; Pharmaceutical and veterinary preparations for medical purposes, namely, contrast agents and contrast media used for X-ray, MRI, or ultrasound imaging; Therapeutic pharmaceuticals, namely, peptides, proteins, small molecules, antibodies, polypeptides, drug-conjugates, lipid nanoparticles, aptamers, liposomes, microparticles, micelles, and polymers for the purpose of providing therapeutic intervention with altered pharmacokinetics and reduced immunogenicity; Pharmaceutical preparations and substances for the treatment of gout, solid and liquid tumors, autoimmune disease, metabolic disorders, cardiovascular disease, infectious disease, and other disorders and diseases treatable with enzyme replacement therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.